Skip to content
Heart icon (animated) heart icon (static)
Our Stories
Page logo

Johnson & Johnson issues statement on FDA order on its manufacturing license
Johnson & Johnson issues statement on FDA order on its manufacturing license

On behalf of a Johnson & Johnson India spokesperson:

Press Statement dated 19 September 2022

We are aware of the Maharashtra FDA order on our manufacturing license. This order was issued on the basis of the pH test result of a single batch of our cosmetic talc. We strongly disagree with this order and will appeal to the authorities within the 90 days’ time given to us.

We would like to assure consumers that the identified batch should no longer be available on shelves as it expired in September 2020. The health of the people who use our products is of utmost importance to us. We stand by the safety of our product.

Back to top